Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

Host cytokine responses distinguish invasive from airway isolates of the Streptococcusmilleri/anginosis group

Authors: Julienne C Kaiser, Chris P Verschoor, Michael G Surette, Dawn ME Bowdish

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

The Streptococcus Milleri/Anginosus Group (SMG) colonize mucosal surfaces, especially the airways, and are considered to be normal mucosal microbiota; however, they are a major cause of abscesses, pneumonia and pleural empyema. The production of exoenzymes and virulence factors do not correlate with SMG pathogenicity. Since SMG infections are associated with robust inflammatory responses, we hypothesized that host immune responses might distinguish strains associated with asymptomatic carriage and those associated with fulminant disease.

Methods

We measured IL1β, TNF, IL10, IL12, IL23, IL17, and IL4 production from human peripheral blood mononuclear cells (PBMCs) stimulated with a panel of clinical isolates from the airways and infections and measured the ability of these isolates to stimulate TLR2.

Results

Isolates were categorized based on the levels of cytokines they induced from PBMCs (high, intermediate, low). Airway isolates predominantly induced low levels of cytokines and isolates from invasive disease induced higher levels, although about 10% of the strains produced divergent cytokine responses between donors. Interestingly, the donors were most divergent in their production of IL17, IL12 and IL23.

Conclusions

We propose that the ability to inhibit or avoid an inflammatory response is associated with carriage in the airways and variability in responses between isolates and donors might contribute to susceptibility to disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Poole PM, Wilson G: Occurrence and cultural features of streptococcus milleri in various body sites. J Clin Pathol. 1979, 32 (8): 764-768. 10.1136/jcp.32.8.764.CrossRefPubMedPubMedCentral Poole PM, Wilson G: Occurrence and cultural features of streptococcus milleri in various body sites. J Clin Pathol. 1979, 32 (8): 764-768. 10.1136/jcp.32.8.764.CrossRefPubMedPubMedCentral
2.
go back to reference Gossling J: Occurrence and pathogenicity of the Streptococcus milleri group. Rev Infect Dis. 1988, 10 (2): 257-285. 10.1093/clinids/10.2.257.CrossRefPubMed Gossling J: Occurrence and pathogenicity of the Streptococcus milleri group. Rev Infect Dis. 1988, 10 (2): 257-285. 10.1093/clinids/10.2.257.CrossRefPubMed
3.
go back to reference Deutschmann MW, Livingstone D, Cho JJ, Vanderkooi OG, Brookes JT: The significance of Streptococcus anginosus group in intracranial complications of pediatric rhinosinusitis. JAMA Otolaryngol Head Neck Surg. 2013, 139 (2): 157-160. 10.1001/jamaoto.2013.1369.CrossRefPubMed Deutschmann MW, Livingstone D, Cho JJ, Vanderkooi OG, Brookes JT: The significance of Streptococcus anginosus group in intracranial complications of pediatric rhinosinusitis. JAMA Otolaryngol Head Neck Surg. 2013, 139 (2): 157-160. 10.1001/jamaoto.2013.1369.CrossRefPubMed
4.
go back to reference Prasad KN, Mishra AM, Gupta D, Husain N, Husain M, Gupta RK: Analysis of microbial etiology and mortality in patients with brain abscess. J Infect. 2006, 53 (4): 221-227. 10.1016/j.jinf.2005.12.002.CrossRefPubMed Prasad KN, Mishra AM, Gupta D, Husain N, Husain M, Gupta RK: Analysis of microbial etiology and mortality in patients with brain abscess. J Infect. 2006, 53 (4): 221-227. 10.1016/j.jinf.2005.12.002.CrossRefPubMed
5.
go back to reference Pang TCY, Fung T, Samra J, Hugh TJ, Smith RC: Pyogenic liver abscess: an audit of 10 years’ experience. World J Gastroenterol. 2011, 17 (12): 1622-1630. 10.3748/wjg.v17.i12.1622.CrossRefPubMedPubMedCentral Pang TCY, Fung T, Samra J, Hugh TJ, Smith RC: Pyogenic liver abscess: an audit of 10 years’ experience. World J Gastroenterol. 2011, 17 (12): 1622-1630. 10.3748/wjg.v17.i12.1622.CrossRefPubMedPubMedCentral
6.
go back to reference Alvarez Perez JA, Gonzalez JJ, Baldonedo RF, Sanz L, Carreno G, Junco A, Rodriguez JI, Martinez MD, Jorge JI: Clinical course, treatment, and multivariate analysis of risk factors for pyogenic liver abscess. Am J Surg. 2001, 181 (2): 177-186. 10.1016/S0002-9610(00)00564-X.CrossRefPubMed Alvarez Perez JA, Gonzalez JJ, Baldonedo RF, Sanz L, Carreno G, Junco A, Rodriguez JI, Martinez MD, Jorge JI: Clinical course, treatment, and multivariate analysis of risk factors for pyogenic liver abscess. Am J Surg. 2001, 181 (2): 177-186. 10.1016/S0002-9610(00)00564-X.CrossRefPubMed
7.
go back to reference Kaplan GG, Gregson DB, Laupland KB: Population-based study of the epidemiology of and the risk factors for pyogenic liver abscess. Clin Gastroenterol Hepatol. 2004, 2 (11): 1032-1038. 10.1016/S1542-3565(04)00459-8.CrossRefPubMed Kaplan GG, Gregson DB, Laupland KB: Population-based study of the epidemiology of and the risk factors for pyogenic liver abscess. Clin Gastroenterol Hepatol. 2004, 2 (11): 1032-1038. 10.1016/S1542-3565(04)00459-8.CrossRefPubMed
8.
go back to reference Lee YQ, Kanagalingam J: Bacteriology of deep neck abscesses: a retrospective review of 96 consecutive cases. Singapore Med J. 2011, 52 (5): 351-355.PubMed Lee YQ, Kanagalingam J: Bacteriology of deep neck abscesses: a retrospective review of 96 consecutive cases. Singapore Med J. 2011, 52 (5): 351-355.PubMed
9.
go back to reference Ahmed RA, Marrie TJ, Huang JQ: Thoracic empyema in patients with community-acquired pneumonia. Am J Med. 2006, 119 (10): 877-883. 10.1016/j.amjmed.2006.03.042.CrossRefPubMed Ahmed RA, Marrie TJ, Huang JQ: Thoracic empyema in patients with community-acquired pneumonia. Am J Med. 2006, 119 (10): 877-883. 10.1016/j.amjmed.2006.03.042.CrossRefPubMed
10.
go back to reference Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, Gabe R, Rees GL, Peto TE, Woodhead MA, Lane DJ, Darbyshire JH, Davies RJ: U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005, 352 (9): 865-874. 10.1056/NEJMoa042473.CrossRefPubMed Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, Gabe R, Rees GL, Peto TE, Woodhead MA, Lane DJ, Darbyshire JH, Davies RJ: U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005, 352 (9): 865-874. 10.1056/NEJMoa042473.CrossRefPubMed
11.
go back to reference Bert F, Bariou-Lancelin M, Lambert-Zechovsky N: Clinical significance of bacteremia involving the “Streptococcus milleri” group: 51 cases and review. Clin Infect Dis. 1998, 27 (2): 385-387. 10.1086/514658.CrossRefPubMed Bert F, Bariou-Lancelin M, Lambert-Zechovsky N: Clinical significance of bacteremia involving the “Streptococcus milleri” group: 51 cases and review. Clin Infect Dis. 1998, 27 (2): 385-387. 10.1086/514658.CrossRefPubMed
12.
go back to reference Sibley CD, Parkins MD, Rabin HR, Duan K, Norgaard JC, Surette MG: A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci U S A. 2008, 105 (39): 15070-15075. 10.1073/pnas.0804326105.CrossRefPubMedPubMedCentral Sibley CD, Parkins MD, Rabin HR, Duan K, Norgaard JC, Surette MG: A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci U S A. 2008, 105 (39): 15070-15075. 10.1073/pnas.0804326105.CrossRefPubMedPubMedCentral
13.
go back to reference Grinwis ME, Sibley CD, Parkins MD, Eshaghurshan CS, Rabin HR, Surette MG: Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis. J Clin Microbiol. 2010, 48 (2): 395-401. 10.1128/JCM.01807-09.CrossRefPubMed Grinwis ME, Sibley CD, Parkins MD, Eshaghurshan CS, Rabin HR, Surette MG: Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis. J Clin Microbiol. 2010, 48 (2): 395-401. 10.1128/JCM.01807-09.CrossRefPubMed
14.
go back to reference Jacobs JA, Stobberingh EE: Hydrolytic enzymes of Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius in relation to infection. Eur J Clin Microbiol Infect Dis. 1995, 14 (9): 818-820. 10.1007/BF01691002.CrossRefPubMed Jacobs JA, Stobberingh EE: Hydrolytic enzymes of Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius in relation to infection. Eur J Clin Microbiol Infect Dis. 1995, 14 (9): 818-820. 10.1007/BF01691002.CrossRefPubMed
15.
go back to reference Damjanovic D, Divangahi M, Kugathasan K, Small CL, Zganiacz A, Brown EG, Hogaboam CM, Gauldie J, Xing Z: Negative regulation of lung inflammation and immunopathology by TNF-alpha during acute influenza infection. Am J Pathol. 2011, 179 (6): 2963-2976. 10.1016/j.ajpath.2011.09.003.CrossRefPubMedPubMedCentral Damjanovic D, Divangahi M, Kugathasan K, Small CL, Zganiacz A, Brown EG, Hogaboam CM, Gauldie J, Xing Z: Negative regulation of lung inflammation and immunopathology by TNF-alpha during acute influenza infection. Am J Pathol. 2011, 179 (6): 2963-2976. 10.1016/j.ajpath.2011.09.003.CrossRefPubMedPubMedCentral
17.
go back to reference Giuliano S, Rubini G, Conte A, Goldoni P, Falcone M, Vena A, Venditti M, Morelli S: Streptococcus anginosus group disseminated infection: case report and review of literature. Infez Med. 2012, 20 (3): 145-154.PubMed Giuliano S, Rubini G, Conte A, Goldoni P, Falcone M, Vena A, Venditti M, Morelli S: Streptococcus anginosus group disseminated infection: case report and review of literature. Infez Med. 2012, 20 (3): 145-154.PubMed
18.
go back to reference Sibley CD, Grinwis ME, Field TR, Eshaghurshan CS, Faria MM, Dowd SE, Parkins MD, Rabin HR, Surette MG: Culture enriched molecular profiling of the cystic fibrosis airway microbiome. PLoS One. 2011, 6 (7): e22702-10.1371/journal.pone.0022702.CrossRefPubMedPubMedCentral Sibley CD, Grinwis ME, Field TR, Eshaghurshan CS, Faria MM, Dowd SE, Parkins MD, Rabin HR, Surette MG: Culture enriched molecular profiling of the cystic fibrosis airway microbiome. PLoS One. 2011, 6 (7): e22702-10.1371/journal.pone.0022702.CrossRefPubMedPubMedCentral
19.
go back to reference Sibley CD, Sibley KA, Leong TA, Grinwis ME, Parkins MD, Rabin HR, Surette MG: The Streptococcus milleri population of a cystic fibrosis clinic reveals patient specificity and intraspecies diversity. J Clin Microbiol. 2010, 48 (7): 2592-2594. 10.1128/JCM.00414-10.CrossRefPubMedPubMedCentral Sibley CD, Sibley KA, Leong TA, Grinwis ME, Parkins MD, Rabin HR, Surette MG: The Streptococcus milleri population of a cystic fibrosis clinic reveals patient specificity and intraspecies diversity. J Clin Microbiol. 2010, 48 (7): 2592-2594. 10.1128/JCM.00414-10.CrossRefPubMedPubMedCentral
20.
go back to reference Larsen JM, Steen-Jensen DB, Laursen JM, Sondergaard JN, Musavian HS, Butt TM, Brix S: Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota. PLoS One. 2012, 7 (2): e31976-10.1371/journal.pone.0031976.CrossRefPubMedPubMedCentral Larsen JM, Steen-Jensen DB, Laursen JM, Sondergaard JN, Musavian HS, Butt TM, Brix S: Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota. PLoS One. 2012, 7 (2): e31976-10.1371/journal.pone.0031976.CrossRefPubMedPubMedCentral
21.
go back to reference Frodermann V, Chau TA, Sayedyahossein S, Toth JM, Heinrichs DE, Madrenas JN: A modulatory interleukin-10 response to staphylococcal peptidoglycan prevents Th1/Th17 adaptive immunity to staphylococcus aureus. J Infect Dis. 2011, 204 (2): 253-262. 10.1093/infdis/jir276.CrossRefPubMed Frodermann V, Chau TA, Sayedyahossein S, Toth JM, Heinrichs DE, Madrenas JN: A modulatory interleukin-10 response to staphylococcal peptidoglycan prevents Th1/Th17 adaptive immunity to staphylococcus aureus. J Infect Dis. 2011, 204 (2): 253-262. 10.1093/infdis/jir276.CrossRefPubMed
22.
go back to reference Peres AG, Madrenas J: The broad landscape of immune interactions with Staphylococcus aureus: from commensalism to lethal infections. Burns. 2013, 39 (3): 380-388. 10.1016/j.burns.2012.12.008.CrossRefPubMed Peres AG, Madrenas J: The broad landscape of immune interactions with Staphylococcus aureus: from commensalism to lethal infections. Burns. 2013, 39 (3): 380-388. 10.1016/j.burns.2012.12.008.CrossRefPubMed
23.
go back to reference Chau TA, McCully ML, Brintnell W, An G, Kasper KJ, Vines ED, Kubes P, Haeryfar SM, McCormick JK, Cairns E, Heinrichs DE, Madrenas J: Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome. Nat Med. 2009, 15 (6): 641-648. 10.1038/nm.1965.CrossRefPubMed Chau TA, McCully ML, Brintnell W, An G, Kasper KJ, Vines ED, Kubes P, Haeryfar SM, McCormick JK, Cairns E, Heinrichs DE, Madrenas J: Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome. Nat Med. 2009, 15 (6): 641-648. 10.1038/nm.1965.CrossRefPubMed
24.
go back to reference Clarridge JE, Osting C, Jalali M, Osborne J, Waddington M: Genotypic and phenotypic characterization of “Streptococcus milleri” group isolates from a veterans administration hospital population. J Clin Microbiol. 1999, 37 (11): 3681-3687.PubMedPubMedCentral Clarridge JE, Osting C, Jalali M, Osborne J, Waddington M: Genotypic and phenotypic characterization of “Streptococcus milleri” group isolates from a veterans administration hospital population. J Clin Microbiol. 1999, 37 (11): 3681-3687.PubMedPubMedCentral
25.
go back to reference Grinwis ME, Sibley CD, Parkins MD, Eshaghurshan CS, Rabin HR, Surette MG: Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients. Antimicrob Agents Chemother. 2010, 54 (7): 2823-2829. 10.1128/AAC.01845-09.CrossRefPubMedPubMedCentral Grinwis ME, Sibley CD, Parkins MD, Eshaghurshan CS, Rabin HR, Surette MG: Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients. Antimicrob Agents Chemother. 2010, 54 (7): 2823-2829. 10.1128/AAC.01845-09.CrossRefPubMedPubMedCentral
26.
go back to reference Whiley RA, Fraser H, Hardie JM, Beighton D: Phenotypic differentiation of Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus strains within the “Streptococcus milleri group”. J Clin Microbiol. 1990, 28 (7): 1497-1501.PubMedPubMedCentral Whiley RA, Fraser H, Hardie JM, Beighton D: Phenotypic differentiation of Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus strains within the “Streptococcus milleri group”. J Clin Microbiol. 1990, 28 (7): 1497-1501.PubMedPubMedCentral
27.
go back to reference Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK: The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science. 2011, 332 (6032): 974-977. 10.1126/science.1206095.CrossRefPubMedPubMedCentral Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK: The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science. 2011, 332 (6032): 974-977. 10.1126/science.1206095.CrossRefPubMedPubMedCentral
28.
go back to reference Jeon SG, Kayama H, Ueda Y, Takahashi T, Asahara T, Tsuji H, Tsuji NM, Kiyono H, Ma JS, Kusu T, Okumura R, Hara H, Yoshida H, Yamamoto M, Nomoto K, Takeda K: Probiotic bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathog. 2012, 8 (5): e1002714-10.1371/journal.ppat.1002714.CrossRefPubMedPubMedCentral Jeon SG, Kayama H, Ueda Y, Takahashi T, Asahara T, Tsuji H, Tsuji NM, Kiyono H, Ma JS, Kusu T, Okumura R, Hara H, Yoshida H, Yamamoto M, Nomoto K, Takeda K: Probiotic bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathog. 2012, 8 (5): e1002714-10.1371/journal.ppat.1002714.CrossRefPubMedPubMedCentral
29.
go back to reference Smits HH, Engering A, van der Kleij D, de Jong EC, Schipper K, van Capel TM, Zaat BA, Yazdanbakhsh M, Wierenga EA, van Kooyk Y, Kapsenberg ML: Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol. 2005, 115 (6): 1260-1267. 10.1016/j.jaci.2005.03.036.CrossRefPubMed Smits HH, Engering A, van der Kleij D, de Jong EC, Schipper K, van Capel TM, Zaat BA, Yazdanbakhsh M, Wierenga EA, van Kooyk Y, Kapsenberg ML: Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol. 2005, 115 (6): 1260-1267. 10.1016/j.jaci.2005.03.036.CrossRefPubMed
30.
go back to reference Cua DJ, Tato CM: Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol. 2010, 10 (7): 479-489. 10.1038/nri2800.CrossRefPubMed Cua DJ, Tato CM: Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol. 2010, 10 (7): 479-489. 10.1038/nri2800.CrossRefPubMed
31.
go back to reference Havarstein LS, Hakenbeck R, Gaustad P: Natural competence in the genus Streptococcus: evidence that streptococci can change pherotype by interspecies recombinational exchanges. J Bacteriol. 1997, 179 (21): 6589-6594.PubMedPubMedCentral Havarstein LS, Hakenbeck R, Gaustad P: Natural competence in the genus Streptococcus: evidence that streptococci can change pherotype by interspecies recombinational exchanges. J Bacteriol. 1997, 179 (21): 6589-6594.PubMedPubMedCentral
32.
go back to reference Olson AB, Kent H, Sibley CD, Grinwis ME, Mabon P, Ouellette C, Tyson S, Graham M, Tyler SD, Van Domselaar G, Surette MG, Corbett CR: Phylogenetic relationship and virulence inference of Streptococcus Anginosus Group: curated annotation and whole-genome comparative analysis support distinct species designation. BMC Genomics. 2013, 14: 895-10.1186/1471-2164-14-895.CrossRefPubMedPubMedCentral Olson AB, Kent H, Sibley CD, Grinwis ME, Mabon P, Ouellette C, Tyson S, Graham M, Tyler SD, Van Domselaar G, Surette MG, Corbett CR: Phylogenetic relationship and virulence inference of Streptococcus Anginosus Group: curated annotation and whole-genome comparative analysis support distinct species designation. BMC Genomics. 2013, 14: 895-10.1186/1471-2164-14-895.CrossRefPubMedPubMedCentral
33.
go back to reference Cho JS, Guo Y, Ramos RI, Hebroni F, Plaisier SB, Xuan C, Granick JL, Matsushima H, Takashima A, Iwakura Y, Cheung AL, Cheng G, Lee DJ, Simon SI, Miller LS: Neutrophil-derived IL-1beta is sufficient for abscess formation in immunity against Staphylococcus aureus in mice. PLoS Pathog. 2012, 8 (11): e1003047-10.1371/journal.ppat.1003047.CrossRefPubMedPubMedCentral Cho JS, Guo Y, Ramos RI, Hebroni F, Plaisier SB, Xuan C, Granick JL, Matsushima H, Takashima A, Iwakura Y, Cheung AL, Cheng G, Lee DJ, Simon SI, Miller LS: Neutrophil-derived IL-1beta is sufficient for abscess formation in immunity against Staphylococcus aureus in mice. PLoS Pathog. 2012, 8 (11): e1003047-10.1371/journal.ppat.1003047.CrossRefPubMedPubMedCentral
34.
go back to reference Vossen MG, Gattringer KB, Khalifeh N, Koreny M, Spertini V, Mallouhi A, Willeit M, Volc-Platzer B, Asboth F, Graninger W, Thalhammer F, Lagler H: Gemella morbillorum bacteremia after anti-tumor necrosis factor alpha as acne inversa therapy. J Clin Microbiol. 2012, 50 (3): 1109-1112. 10.1128/JCM.06161-11.CrossRefPubMedPubMedCentral Vossen MG, Gattringer KB, Khalifeh N, Koreny M, Spertini V, Mallouhi A, Willeit M, Volc-Platzer B, Asboth F, Graninger W, Thalhammer F, Lagler H: Gemella morbillorum bacteremia after anti-tumor necrosis factor alpha as acne inversa therapy. J Clin Microbiol. 2012, 50 (3): 1109-1112. 10.1128/JCM.06161-11.CrossRefPubMedPubMedCentral
35.
go back to reference Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, Basham B, Smith K, Chen T, Morel F, Lecron JC, Kastelein RA, Cua DJ, McClanahan TK, Bowman EP, de Waal Malefyt R: Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol. 2007, 8 (9): 950-957. 10.1038/ni1497.CrossRefPubMed Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, Basham B, Smith K, Chen T, Morel F, Lecron JC, Kastelein RA, Cua DJ, McClanahan TK, Bowman EP, de Waal Malefyt R: Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol. 2007, 8 (9): 950-957. 10.1038/ni1497.CrossRefPubMed
36.
go back to reference Manel N, Unutmaz D, Littman DR: The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol. 2008, 9 (6): 641-649. 10.1038/ni.1610.CrossRefPubMedPubMedCentral Manel N, Unutmaz D, Littman DR: The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol. 2008, 9 (6): 641-649. 10.1038/ni.1610.CrossRefPubMedPubMedCentral
37.
go back to reference Hoeve MA, Savage ND, de Boer T, Langenberg DM, de Waal MR, Ottenhoff TH, Verreck FA: Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur J Immunol. 2006, 36 (3): 661-670. 10.1002/eji.200535239.CrossRefPubMed Hoeve MA, Savage ND, de Boer T, Langenberg DM, de Waal MR, Ottenhoff TH, Verreck FA: Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur J Immunol. 2006, 36 (3): 661-670. 10.1002/eji.200535239.CrossRefPubMed
38.
go back to reference Zhang Z, Clarke TB, Weiser JN: Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest. 2009, 119 (7): 1899-1909.PubMedPubMedCentral Zhang Z, Clarke TB, Weiser JN: Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest. 2009, 119 (7): 1899-1909.PubMedPubMedCentral
39.
go back to reference Lu YJ, Gross J, Bogaert D, Finn A, Bagrade L, Zhang Q, Kolls JK, Srivastava A, Lundgren A, Forte S, Thompson CM, Harney KF, Anderson PW, Lipsitch M, Malley R: Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 2008, 4 (9): e1000159-10.1371/journal.ppat.1000159.CrossRefPubMedPubMedCentral Lu YJ, Gross J, Bogaert D, Finn A, Bagrade L, Zhang Q, Kolls JK, Srivastava A, Lundgren A, Forte S, Thompson CM, Harney KF, Anderson PW, Lipsitch M, Malley R: Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 2008, 4 (9): e1000159-10.1371/journal.ppat.1000159.CrossRefPubMedPubMedCentral
40.
go back to reference Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, Husain S, Kreindler JL, Dubin PJ, Pilewski JM, Myerburg MM, Mason CA, Iwakura Y, Kolls JK: IL-22 mediates mucosal host defense against gram-negative bacterial pneumonia. Nat Med. 2008, 14 (3): 275-281. 10.1038/nm1710.CrossRefPubMedPubMedCentral Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, Husain S, Kreindler JL, Dubin PJ, Pilewski JM, Myerburg MM, Mason CA, Iwakura Y, Kolls JK: IL-22 mediates mucosal host defense against gram-negative bacterial pneumonia. Nat Med. 2008, 14 (3): 275-281. 10.1038/nm1710.CrossRefPubMedPubMedCentral
41.
go back to reference Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, Bagby GJ, Nelson S, Charrier K, Peschon JJ, Kolls JK: Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exper Med. 2001, 194 (4): 519-527. 10.1084/jem.194.4.519.CrossRef Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, Bagby GJ, Nelson S, Charrier K, Peschon JJ, Kolls JK: Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exper Med. 2001, 194 (4): 519-527. 10.1084/jem.194.4.519.CrossRef
42.
go back to reference Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL: Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med. 2009, 206 (2): 299-311. 10.1084/jem.20081463.CrossRefPubMedPubMedCentral Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL: Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med. 2009, 206 (2): 299-311. 10.1084/jem.20081463.CrossRefPubMedPubMedCentral
43.
go back to reference Pandiyan P, Conti HR, Zheng L, Peterson AC, Mathern DR, Hernandez-Santos N, Edgerton M, Gaffen SL, Lenardo MJ: CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity. 2011, 34 (3): 422-434. 10.1016/j.immuni.2011.03.002.CrossRefPubMedPubMedCentral Pandiyan P, Conti HR, Zheng L, Peterson AC, Mathern DR, Hernandez-Santos N, Edgerton M, Gaffen SL, Lenardo MJ: CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity. 2011, 34 (3): 422-434. 10.1016/j.immuni.2011.03.002.CrossRefPubMedPubMedCentral
44.
go back to reference Hernandez-Santos N, Huppler AR, Peterson AC, Khader SA, McKenna KC, Gaffen SL: Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections. Mucosal Immunol. 2013, 6 (5): 900-910. 10.1038/mi.2012.128.CrossRefPubMed Hernandez-Santos N, Huppler AR, Peterson AC, Khader SA, McKenna KC, Gaffen SL: Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections. Mucosal Immunol. 2013, 6 (5): 900-910. 10.1038/mi.2012.128.CrossRefPubMed
45.
go back to reference Miyamoto M, Prause O, Sjostrand M, Laan M, Lotvall J, Linden A: Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol. 2003, 170 (9): 4665-4672. 10.4049/jimmunol.170.9.4665.CrossRefPubMed Miyamoto M, Prause O, Sjostrand M, Laan M, Lotvall J, Linden A: Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol. 2003, 170 (9): 4665-4672. 10.4049/jimmunol.170.9.4665.CrossRefPubMed
46.
go back to reference Laan M, Cui ZH, Hoshino H, Lotvall J, Sjostrand M, Gruenert DC, Skoogh BE, Linden A: Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol. 1999, 162 (4): 2347-2352.PubMed Laan M, Cui ZH, Hoshino H, Lotvall J, Sjostrand M, Gruenert DC, Skoogh BE, Linden A: Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol. 1999, 162 (4): 2347-2352.PubMed
47.
go back to reference Rose WE, Eickhoff JC, Shukla SK, Pantrangi M, Rooijakkers S, Cosgrove SE, Nizet V, Sakoulas G: Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia. J Infect Dis. 2012, 206 (10): 1604-1611. 10.1093/infdis/jis552.CrossRefPubMed Rose WE, Eickhoff JC, Shukla SK, Pantrangi M, Rooijakkers S, Cosgrove SE, Nizet V, Sakoulas G: Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia. J Infect Dis. 2012, 206 (10): 1604-1611. 10.1093/infdis/jis552.CrossRefPubMed
48.
go back to reference Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JA, van Keulen PH, Vandenbroucke-Grauls CM, Meester MH, Verbrugh HA: Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet. 2004, 364 (9435): 703-705. 10.1016/S0140-6736(04)16897-9.CrossRefPubMed Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JA, van Keulen PH, Vandenbroucke-Grauls CM, Meester MH, Verbrugh HA: Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet. 2004, 364 (9435): 703-705. 10.1016/S0140-6736(04)16897-9.CrossRefPubMed
49.
go back to reference Holt PG, Strickland DH, Wikstrom ME, Jahnsen FL: Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol. 2008, 8 (2): 142-152. 10.1038/nri2236.CrossRefPubMed Holt PG, Strickland DH, Wikstrom ME, Jahnsen FL: Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol. 2008, 8 (2): 142-152. 10.1038/nri2236.CrossRefPubMed
Metadata
Title
Host cytokine responses distinguish invasive from airway isolates of the Streptococcusmilleri/anginosis group
Authors
Julienne C Kaiser
Chris P Verschoor
Michael G Surette
Dawn ME Bowdish
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-498

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.